The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Applications of nanoparticles for diagnosis and therapy of cancer
Open accessAbstract
During the last decades, a plethora of nanoparticles have been developed and evaluated and a real hype has been created around their potential application as diagnostic and therapeutic agents. Despite their suggestion as potential diagnostic agents, only a single diagnostic nanoparticle formulation, namely iron oxide nanoparticles, has found its way into clinical routine so far. This fact is primarily due to difficulties in achieving appropriate pharmacokinetic properties and a reproducible synthesis of monodispersed nanoparticles. Furthermore, concerns exist about their biodegradation, elimination and toxicity. The majority of nanoparticle formulations that are currently routinely used in the clinic are used for therapeutic purposes. These therapeutic nanoparticles aim to more efficiently deliver a (chemo-) therapeutic drug to the pathological site, while avoiding its accumulation in healthy organs and tissues, and are predominantly based on the "enhanced permeability and retention" (EPR) effect. Furthermore, based on their ability to integrate diagnostic and therapeutic entities within a single nanoparticle formulation, nanoparticles hold great promise for theranostic purposes and are considered to be highly useful for personalizing nanomedicine-based treatments. In this review article, we present applications of diagnostic and therapeutic nanoparticles, summarize frequently used non-invasive imaging techniques and describe the role of EPR in the accumulation of nanotheranostic formulations. In this context, the clinical potential of nanotheranostics and image-guided drug delivery for individualized and improved (chemo-) therapeutic interventions is addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Imaging in the era of molecular oncology
Weissleder, R., & Pittet, M. J. (2008) · Nature · doi:10.1038/nature06917 · Cited by 2,364
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
Kim, S., Lim, Y. T., Soltesz, E. G., De Grand, A. M., Lee, J., Nakayama, A., Parker, J. A., Mihaljevic, T., Laurence, R. G., Dor, D. M., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt920 · Cited by 2,087
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Carbon nanotubes as photoacoustic molecular imaging agents in living mice
De La Zerda, A., Zavaleta, C., Keren, S., Vaithilingam, S., Bodapati, S., Liu, Z., Levi, J., Smith, B. R., Ma, T.-J., Oralkan, O., et al. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.231 · Cited by 1,271
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Mohanraj, V. J., & Chen, Y. (2007) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v5i1.14634 · Cited by 1,217
Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912273 · Cited by 1,147
Kircher, M. F., de la Zerda, A., Jokerst, J. V., Zavaleta, C. L., Kempen, P. J., Mittra, E., Pitter, K., Huang, R., Campos, C., Habte, F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2721 · Cited by 1,064
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles
Rabin, O., Manuel Perez, J., Grimm, J., Wojtkiewicz, G., & Weissleder, R. (2006) · Nature Materials · doi:10.1038/nmat1571 · Cited by 942
Lammers, T., Aime, S., Hennink, W. E., Storm, G., & Kiessling, F. (2011) · Accounts of Chemical Research · doi:10.1021/ar200019c · Cited by 870
Self-citationClinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Phillips, E., Penate-Medina, O., Zanzonico, P. B., Carvajal, R. D., Mohan, P., Ye, Y., Humm, J., Gönen, M., Kalaigian, H., Schöder, H., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009524 · Cited by 712
Multifunctional Nanoparticles for Drug Delivery and Molecular Imaging
Bao, G., Mitragotri, S., & Tong, S. (2013) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071812-152409 · Cited by 536
Nanotheranostics for personalized medicine
Mura, S., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.006 · Cited by 527
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Zhang, X.-Q., Xu, X., Bertrand, N., Pridgen, E., Swami, A., & Farokhzad, O. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.005 · Cited by 487
Theranostic Nanomedicine for Cancer
Sumer, B., & Gao, J. (2008) · Nanomedicine · doi:10.2217/17435889.3.2.137 · Cited by 478
Nanotheranostics and image-guided drug delivery: current concepts and future directions
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100228v · Cited by 397
Self-citationEmerging applications for ferumoxytol as a contrast agent in MRI
Bashir, M. R., Bhatti, L., Marin, D., & Nelson, R. C. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24691 · Cited by 371
Grüll, H., & Langereis, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.041 · Cited by 360
Kim, K., Kim, J. H., Park, H., Kim, Y.-S., Park, K., Nam, H., Lee, S., Park, J. H., Park, R.-W., & Kim, I.-S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.004 · Cited by 347
Tumoral Distribution of Long-circulating Dextran-coated Iron Oxide Nanoparticles in a Rodent Model
Moore, A., Marecos, E., Bogdanov, A., & Weissleder, R. (2000) · Radiology · doi:10.1148/radiology.214.2.r00fe19568 · Cited by 343
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications
Rizzo, L. Y., Theek, B., Storm, G., Kiessling, F., & Lammers, T. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.02.020 · Cited by 336
Self-citationZhang, C., Jugold, M., Woenne, E. C., Lammers, T., Morgenstern, B., Mueller, M. M., Zentgraf, H., Bock, M., Eisenhut, M., Semmler, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1668 · Cited by 336
Self-citationPassive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines
Kunjachan, S., Pola, R., Gremse, F., Theek, B., Ehling, J., Moeckel, D., Hermanns-Sachweh, B., Pechar, M., Ulbrich, K., Hennink, W. E., et al. (2014) · Nano Letters · doi:10.1021/nl404391r · Cited by 317
Self-citationDrug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy
Gao, Z., Kennedy, A. M., Christensen, D. A., & Rapoport, N. Y. (2008) · Ultrasonics · doi:10.1016/j.ultras.2007.11.002 · Cited by 316
Seymour (2009) · International Journal of Oncology · doi:10.3892/ijo_00000293 · Cited by 304
Nanoparticles for multimodal in vivo imaging in nanomedicine
Leary, J., & Key, J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s53717 · Cited by 300
MRI Contrast Agents: Current Status and Future Perspectives
Strijkers, G. J., M. Mulder, W. J., F. van Tilborg, G. A., & Nicolay, K. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007780618135 · Cited by 275
Nanotechnology in Medical Imaging: Probe Design and Applications
Cormode, D. P., Skajaa, T., Fayad, Z. A., & Mulder, W. J. M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.165506 · Cited by 275
Safety assessment of nanomaterials: Implications for nanomedicine
Nyström, A. M., & Fadeel, B. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.027 · Cited by 264
Mulder, W. J. M., Strijkers, G. J., Habets, J. W., Bleeker, E. J. W., van der Schaft, D. W. J., Storm, G., Koning, G. A., Griffioen, A. W., & Nicolay, K. (2005) · The FASEB Journal · doi:10.1096/fj.05-4145fje · Cited by 259
Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
Greish, K., Nehoff, H., Parayath, N., Domanovitch, L., & Taurin, S. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s47129 · Cited by 238
Nanoparticles for Imaging: top or Flop?
Kiessling, F., Mertens, M. E., Grimm, J., & Lammers, T. (2014) · Radiology · doi:10.1148/radiol.14131520 · Cited by 228
Nanotheranostics for personalized medicine
Kim, T. H., Lee, S., & Chen, X. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.13.15 · Cited by 222
Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles
Schmitz, S. A., Taupitz, M., Wagner, S., Wolf, K., Beyersdorff, D., & Hamm, B. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1194 · Cited by 208
Computed Tomography: Revolutionizing the Practice of Medicine for 40 Years
Rubin, G. D. (2014) · Radiology · doi:10.1148/radiol.14141356 · Cited by 197
Lammers, T., Rizzo, L. Y., Storm, G., & Kiessling, F. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1414 · Cited by 195
Self-citationAkers, W. J., Kim, C., Berezin, M., Guo, K., Fuhrhop, R., Lanza, G. M., Fischer, G. M., Daltrozzo, E., Zumbusch, A., Cai, X., et al. (2011) · ACS Nano · doi:10.1021/nn102274q · Cited by 192
Kim, Y., Jeon, J., Hong, S. H., Rhim, W., Lee, Y., Youn, H., Chung, J., Lee, M. C., Lee, D. S., Kang, K. W., et al. (2011) · Small · doi:10.1002/smll.201100927 · Cited by 189
Inorganic Nanoparticles Based Contrast Agents for X‐ray Computed Tomography
Jakhmola, A., Anton, N., & Vandamme, T. F. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200032 · Cited by 184
Chen, X., Gambhir, S. S., & Cheon, J. (2011) · Accounts of Chemical Research · doi:10.1021/ar200231d · Cited by 183
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
Scheinberg, D. A., Villa, C. H., Escorcia, F. E., & McDevitt, M. R. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.38 · Cited by 180
Nanotechnology in cancer therapy
Aslan, B., Ozpolat, B., Sood, A. K., & Lopez-Berestein, G. (2013) · Journal of Drug Targeting · doi:10.3109/1061186x.2013.837469 · Cited by 180
Palmowski, M., Huppert, J., Ladewig, G., Hauff, P., Reinhardt, M., Mueller, M. M., Woenne, E. C., Jenne, J. W., Maurer, M., Kauffmann, G. W., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0409 · Cited by 170
Self-citationBiologically Optimized Nanosized Molecules and Particles: More than Just Size
Longmire, M. R., Ogawa, M., Choyke, P. L., & Kobayashi, H. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200111p · Cited by 167
A Temperature-Sensitive Liposomal 1H CEST and 19F Contrast Agent for MR Image-Guided Drug Delivery
Langereis, S., Keupp, J., van Velthoven, J. L. J., de Roos, I. H. C., Burdinski, D., Pikkemaat, J. A., & Grüll, H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8087532 · Cited by 166
In vivo magnetic resonance imaging of hyperpolarized silicon particles
Cassidy, M. C., Chan, H. R., Ross, B. D., Bhattacharya, P. K., & Marcus, C. M. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.65 · Cited by 162
Pysz, M. A., Foygel, K., Rosenberg, J., Gambhir, S. S., Schneider, M., & Willmann, J. K. (2010) · Radiology · doi:10.1148/radiol.10091858 · Cited by 160
Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques
Majmudar, M. D., Yoo, J., Keliher, E. J., Truelove, J. J., Iwamoto, Y., Sena, B. F., Dutta, P., Borodovsky, A., Fitzgerald, K. J., Carli, M. F. D., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300576 · Cited by 158
Theranostic USPIO‐Loaded Microbubbles for Mediating and Monitoring Blood‐Brain Barrier Permeation
Lammers, T., Koczera, P., Fokong, S., Gremse, F., Ehling, J., Vogt, M., Pich, A., Storm, G., van Zandvoort, M., & Kiessling, F. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201401199 · Cited by 156
Self-citationTheranostics: Are We There Yet?
Svenson, S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300644n · Cited by 156
Advance of Molecular Imaging Technology and Targeted Imaging Agent in Imaging and Therapy
Chen, Z., Wáng, Y. X. J., Lin, Y., Zhang, J., Yang, F., Zhou, Q.-L., & Liao, Y. (2014) · BioMed Research International · doi:10.1155/2014/819324 · Cited by 148
Soundararajan, A., Bao, A., Phillips, W. T., Perez, R., & Goins, B. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.02.004 · Cited by 145
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
Lammers, T., Šubr, V., Peschke, P., Kühnlein, R., Hennink, W. E., Ulbrich, K., Kiessling, F. M., Heilmann, M., Debus, J., Huber, P. E., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604561 · Cited by 141
Self-citationFluorescent Nanoparticle Probes for Cancer Imaging
Santra, S., Dutta, D., Walter, G. A., & Moudgil, B. M. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400603 · Cited by 136
Rappeport, E. D., Loft, A., Berthelsen, A. K., von der Recke, P., Larsen, P. N., Mogensen, A. M., Wettergren, A., Rasmussen, A., Hillingsø, J., Kirkegaard, P. O., et al. (2007) · Acta Radiologica · doi:10.1080/02841850701294560 · Cited by 130
Koukouraki, A. M. I. K. S. (2000) · Acta Oncologica · doi:10.1080/028418600430789 · Cited by 128
CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles
Torchilin, V. P., Frank-Kamenetsky, M. D., & Wolf, G. L. (1999) · Academic Radiology · doi:10.1016/s1076-6332(99)80063-4 · Cited by 120
Bzyl, J., Lederle, W., Rix, A., Grouls, C., Tardy, I., Pochon, S., Siepmann, M., Penzkofer, T., Schneider, M., Kiessling, F. M., et al. (2011) · European Radiology · doi:10.1007/s00330-011-2138-y · Cited by 111
Self-citationNanobubbles from Gas‐Generating Polymeric Nanoparticles: Ultrasound Imaging of Living Subjects
Kang, E., Min, H. S., Lee, J., Han, M. H., Ahn, H. J., Yoon, I., Choi, K., Kim, K., Park, K., & Kwon, I. C. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200903841 · Cited by 109
Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching
Kaittanis, C., Shaffer, T. M., Ogirala, A., Santra, S., Perez, J. M., Chiosis, G., Li, Y., Josephson, L., & Grimm, J. (2014) · Nature Communications · doi:10.1038/ncomms4384 · Cited by 107
Targeted PARACEST nanoparticle contrast agent for the detection of fibrin
Winter, P. M., Cai, K., Chen, J., Adair, C. R., Kiefer, G. E., Athey, P. S., Gaffney, P. J., Buff, C. E., Robertson, J. D., Caruthers, S. D., et al. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21093 · Cited by 105
Xie, H., Wang, Z. J., Bao, A., Goins, B., & Phillips, W. T. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.005 · Cited by 102
Liu, Y., Ai, K., Liu, J., Yuan, Q., He, Y., & Lu, L. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200028 · Cited by 96
Sever, A. R., Mills, P., Weeks, J., Jones, S. E., Fish, D. E., Jones, P. A., & Mali, W. P. T. M. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7702 · Cited by 92
Cai, X., Li, W., Kim, C., Yuan, Y., Wang, L. V., & Younan Xia, A. (2011) · ACS Nano · doi:10.1021/nn203124x · Cited by 91
The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide
Weissleder, R., Elizondo, G., Stark, D. D., Hahn, P. F., Marfil, J., Gonzalez, J., Saini, S., Todd, L., & Ferrucci, J. T. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.152.1.175 · Cited by 86
Non-invasive imaging for studying anti-angiogenic therapy effects
Ehling, J., Lammers, T., & Kiessling, F. M. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-10-0721 · Cited by 84
Self-citationSMART drug delivery systems: Back to the future vs. clinical reality
Lammers, T. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.046 · Cited by 80
Self-citationOcampo‐García, B., Ramı́rez, F. D. M., Ferro‐Flores, G., Rodriguez, L. M. D. L., Santos‐Cuevas, C., Morales-Ávila, E., de Murphy, C. A., Pedraza-López, M., Medina, L. A., & Camacho-López, M. A. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.07.007 · Cited by 76
Early in vivo assessment of angiostatic therapy efficacy by molecular MRI
Mulder, W. J. M., van der Schaft, D. W. J., Hautvast, P. A. I., Strijkers, G. J., Koning, G. A., Storm, G., Mayo, K. H., Griffioen, A. W., & Nicolay, K. (2007) · The FASEB Journal · doi:10.1096/fj.06-6791com · Cited by 76
The theranostic path to personalized nanomedicine
Theek, B., Rizzo, L. Y., Ehling, J., Kiessling, F. M., & Lammers, T. (2014) · Clinical and Translational Imaging · doi:10.1007/s40336-014-0051-5 · Cited by 74
Self-citationContrast Agents and Applications to Assess Tumor Angiogenesis In Vivo by Magnetic Resonance Imaging
Kiessling, F. M., Morgenstern, B., & Zhang, C. (2006) · Current Medicinal Chemistry · doi:10.2174/092986707779313516 · Cited by 71
Self-citationMaurer, A. H., Elsinga, P. H., Fanti, S., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.133074 · Cited by 70
Preda, A., van Vliet, M., Krestin, G. P., Brasch, R. C., & van Dijke, C. F. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000186565.21375.88 · Cited by 58
Targeted Ultrasound Imaging of Cancer: An Emerging Technology on its Way to Clinics
Kiessling, F. M., Bzyl, J., Fokong, S., Siepmann, M., Schmitz, G., & Palmowski, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800099900 · Cited by 57
Self-citationWill Nanotechnology Influence Targeted Cancer Therapy?
Grimm, J., & Scheinberg, D. A. (2011) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.10.003 · Cited by 50
Theranostic Systems and Strategies for Monitoring Nanomedicine-Mediated Drug Targeting
Kunjachan, S., Jayapaul, J., Mertens, M. E., Storm, G., Kiessling, F. M., & Lammers, T. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112799436302 · Cited by 41
Self-citationSoundararajan, A., Dodd, G. D., Bao, A., Phillips, W. T., McManus, L. M., Prihoda, T. J., & Goins, B. (2011) · Radiology · doi:10.1148/radiol.11110361 · Cited by 39
Blood pool and liver enhancement in CT with liposomal lodixanol: Comparison with lohexol
Desser, T. S., Rubin, D. L., Muller, H. H., McIntire, G. L., Bacon, E. R., & Toner, J. L. (1999) · Academic Radiology · doi:10.1016/s1076-6332(99)80404-8 · Cited by 34
Dawn of Advanced Molecular Medicine: Nanotechnological Advancements in Cancer Imaging and Therapy
Kaittanis, C., Shaffer, T. M., Thorek, D. L. J., & Grimm, J. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014011601 · Cited by 25
Angiogenesis imaging with vascular-constrained particles: the why and how
Lanza, G. M., Caruthers, S. D., Winter, P. M., Hughes, M. S., Schmieder, A. H., Hu, G., & Wickline, S. A. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1502-5 · Cited by 24
Biodistribution and Ct-Imaging Characteristics of Iopromide-Carrying Liposomes in Rats
LEIKE, J. U., Sachse, A., & Ehritt, C. (1996) · Journal of Liposome Research · doi:10.3109/08982109609039920 · Cited by 11
Cited by
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties
Sukhanova, A., Bozrova, S., Sokolov, P., Berestovoy, M., Karaulov, A., & Nabiev, I. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2457-x · Cited by 1,107
Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 461
Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
Zhao, Z., Ukidve, A., Krishnan, V., & Mitragotri, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.002 · Cited by 444
Application of Nanomaterials in Biomedical Imaging and Cancer Therapy
Siddique, S., & Chow, J. C. L. (2020) · Nanomaterials · doi:10.3390/nano10091700 · Cited by 402
Metadata
- Authors
- Baetke, S. C., Lammers, T., & Kiessling, F.
- Venue
- The British Journal of Radiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10
- Volume
- 88
- Issue
- 1054
- Pages
- 20150207
- ISSN
- 0007-1285 (ISSN-L)
- 1748-880X
- OpenAlex
- W1928083400
- Cited by
- 494
- References
- 95
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.